Premarket Gainers: XBIT +17%.
QIWI +12%.
GTXI +12% on announcement of positive interim results from a Phase 2 proof-of-concept study assessing enobosarm (GTx-024) for the treatment of postmenopausal women with stress urinary incontinence.
RWLK +11% ON announcement that a Florida court ruling that found Blue Cross Blue Shield of Florida must provide coverage of a ReWalk exoskeleton system for a plan member with a spinal cord injury.
ABIL +10%.
Submitted June 12, 2017 at 09:49AM by SueBid http://ift.tt/2sku5Rt
